Product Details

Product Manufacturing Process

The manufacturing of the China Influenza Test involves multiple stages, including designing, prototyping, and rigorous testing for accuracy in detecting viral antigens. According to a study published in the Journal of Clinical Microbiology, assay development focuses on optimizing sensitivity and specificity. The production process under stringent quality control ensures reliable performance. The final product is verified through clinical trials to confirm its efficacy in diagnosing influenza and SARS-CoV-2 infections. Continuous improvements and feedback integration are key aspects of the process, enhancing the diagnostic capabilities and ensuring consistency across batches.

Product Application Scenarios

According to authoritative studies, the China Influenza Test is particularly suited for use in clinical settings such as hospitals and clinics where rapid diagnosis is critical. It facilitates the immediate differentiation between influenza and COVID-19 infections, enabling timely medical intervention. The test is also valuable in public health surveillance programs to monitor virus spread during seasonal outbreaks. Its application ensures optimal patient management, reduces hospital stays, and aids in the decision-making process for antiviral treatment. Additionally, it is a vital tool in controlling infection spread within communities and healthcare facilities by providing quick and accurate diagnoses.

Product After-Sales Service

We provide comprehensive after-sales support, including technical assistance and guidance for interpreting test results. Our dedicated customer service team in China is available to address any inquiries or concerns, ensuring customer satisfaction. Replacement policies are in place for any defective products.

Product Transportation

The China Influenza Test is securely packaged to maintain integrity during transit. We offer reliable shipping solutions, with options for express delivery to ensure timely availability.

Product Advantages

• Rapid results, enhancing clinical decision-making.
• Highly reliable with a CE certification.
• Convenient and easy to use in various healthcare settings.

Product FAQ

• What is the China Influenza Test designed for?

  The China Influenza Test is designed for the rapid detection of Influenza AB and SARS-COV-2 antigens. It helps differentiate between flu and COVID-19 infections.

• How to collect specimens for the test?

  Use nasopharyngeal or nasal swabs for specimen collection. Ensure samples are collected properly for accurate results.

• What is the reading time for the test?

  The results are available within 10 minutes, providing quick diagnostic aid.

• Is the test CE certified?

  Yes, the China Influenza Test is CE certified, ensuring compliance with European safety and performance standards.

• Can the test be used in clinics?

  Yes, it's suitable for use in clinics and hospitals, offering rapid and reliable results to aid healthcare professionals.

• What are the storage requirements?

  Store the test at temperatures between 2-30°C for optimal preservation and performance.

• How long is the shelf life?

  The test has a shelf life of 2 years, ensuring long-term usability.

• What should be done if a test is invalid?

  If the control band fails to appear, discard the test and repeat with a new one. If issues persist, contact the distributor.

• What are the advantages of using this test?

  Quick results, ease of use, and high reliability make it a preferred choice for influenza and COVID-19 detection in China.

• Does it differentiate between Flu A and B?

  Yes, the test can distinguish between Flu A and B, aiding in precise diagnosis and treatment decisions.

Product Hot Topics

• Influenza Testing in China: A Critical Component

  The critical role of influenza testing in China cannot be understated, particularly in light of emerging and re-emerging viral threats. Effective testing, by products like the China Influenza Test, supports public health strategies and enhances patient care. Its rapid results are invaluable for timely virus containment and management, distinguishing it as a significant tool in the healthcare sector.

• The Evolution of Influenza Tests in China

  Over the years, influenza tests in China have evolved, incorporating advanced technologies that improve sensitivity and specificity. Innovations spearheaded by companies like QL Biotech play a crucial role in advancing diagnostic methodologies. This evolution reflects a commitment to better health standards and preparedness for influenza-related challenges.

Image Description